Label: ANTIGEN COMPONENT- cov-2 pres dtm antigen injection, emulsion

  • Category: VACCINE LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

Drug Label Information

Updated November 9, 2020

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Health Care Professional and Patient Fact Sheets are not available at this time.

  • PRINCIPAL DISPLAY PANEL - 10 Dose Vial Label

    NDC 49281-618-78
    Vial 1 of 2
    ANTIGEN COMPONENT
    for Sanofi Pasteur COVID-19 Vaccine, Adjuvanted

    After mixing, emulsion for intramuscular injection
    For use under Emergency Use Authorization.
    NOT TO BE USED ALONE.
    Add 1 vial of AS03 Adjuvant Component to form the Vaccine.
    Multiple Dose Vial (after mixing, contains 10 doses of 0.5 mL). After
    mixing, hold at 23°C to 27°C (73°F to 80°F). Discard after 6 hours.
    Refer to FDA-authorized Fact Sheet for mixing instructions.
    No Preservative
    Record date and time of mixing:
    Manufactured by: Sanofi Pasteur Inc.

    PRINCIPAL DISPLAY PANEL - 10 Vial Label
  • PRINCIPAL DISPLAY PANEL - 10 Vial Carton

    NDC 49281-618-20
    ANTIGEN COMPONENT
    for Sanofi Pasteur COVID-19 Vaccine, Adjuvanted

    After mixing, emulsion for intramuscular injection
    For use under Emergency Use Authorization

    CONTENTS: 10 Multiple Dose Vials (after mixing with AS03 Adjuvant Component,
    each vial contains ten 0.5 mL doses of Vaccine)

    NOTICE: NOT TO BE USED ALONE
    One vial of AS03 Adjuvant Component MUST BE ADDED to one vial of
    Antigen Component to form the Vaccine.

    794426

    SANOFI PASTEUR

    PRINCIPAL DISPLAY PANEL - 10 Vial Carton
  • INGREDIENTS AND APPEARANCE
    ANTIGEN COMPONENT 
    cov-2 pres dtm antigen injection, emulsion
    Product Information
    Product TypeVACCINEItem Code (Source)NDC:49281-618
    Route of AdministrationINTRAMUSCULAR
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    COV-2 PRES DTM ANTIGEN (UNII: 76SQ8FDG7I) (COV-2 PRES DTM ANTIGEN - UNII:76SQ8FDG7I) COV-2 PRES DTM ANTIGEN50 ug  in 2.5 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 22 mg  in 2.5 mL
    SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE (UNII: E1W4N241FO) 6.5 mg  in 2.5 mL
    SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) 0.975 mg  in 2.5 mL
    POLYSORBATE 20 (UNII: 7T1F30V5YH) 13.75 mg  in 2.5 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:49281-618-2010 in 1 CARTON
    1NDC:49281-618-782.5 mL in 1 VIAL, MULTI-DOSE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    UNAPPROVED DRUG OTHER11/10/2020
    Labeler - Sanofi Pasteur Inc. (086723285)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sanofi Pasteur Inc.086723285MANUFACTURE(49281-618)